Info@ThinkPinkRocks.com

Two-year data show continued survival advantage for self-expanding TAVR

Two-year data show a continued survival advantage for self-expanding transcatheter aortic valve replacement (TAVR) over standard surgery in high-risk patients with severe aortic stenosis, according to research presented at the American College of Cardiology’s 64th Annual Scientific Session.

View post:
Two-year data show continued survival advantage for self-expanding TAVR

Share

Leave a Reply